Cretostimogene treatment shows best-in-class durability of response for BCG-unresponsive non-muscle invasive bladder cancer ...

The company’s Phase I trial found that patients remained disease free after three months utilising the lowest doses of RAG-01 ...

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...

one covering the use of its technologies to generate multiple CAR-T therapy candidates for cancer and a second giving AbbVie rights to lead candidate UB-VV111, a CD19-directed in situ CAR-T for ...

New trends data show significant reduction in the incidence of precancerous lesions in young women since advent of vaccine.